Guide to Atherosclerosis

Tasigna may have life-threatening and serious unwanted effects, including the development of atherosclerosis.

After the medication was approved by the U.S. Food and Drug Administration (FDA) in 2007, it transported warnings for a number of the significant unwanted effects, however no caution regarding atherosclerosis.

In 2013, a warning regarding the threat has been issued in Canada; however, no such warning letter has been issued at the U.S.

A lot of studies have discovered a connection between Tasigna usage and atherosclerosis, nine of which have been printed in 2013 alone. Among those 2013 research was an FDA postmarked review.

The agency said that the research strongly implies an association between nilotinib and PAOD. That year, a warning letter has been sent to physicians in Canada, but not at the U.S.

Tasigna Atherosclerosis Lawsuits

Hazards of Atherosclerosis

Atherosclerosis is a really serious medical condition which could have life-threatening or deadly complications. You can contact Tasigna lawyers from this source: Tasigna Atherosclerosis Attorneys Handling National Tasigna Lawsuits.

Hazards of atherosclerosis include:

  • Coronary heart disease
  • Peripheral artery disease
  • Carotid artery disease
  • Heart attack
  • Stroke
  • Embolic occlusion
  • Circulatory problems resulting in gangrene and amputation
  • Chronic kidney disease

Other Serious Side Effects

Tasigna may also have other really serious side effects such as:

  • Pancreatitis
  • Liver Issues
  • Kidney Issues
  • Low blood count
  • QT prolongation
  • Sudden death

If you think that your injuries or the death of a loved person were induced by Tasigna, please consult with an expert defective drug attorney immediately to find out more about your rights and possible payment.